Events

CMO Summit

Vibe Bio Cafe

Join Vibe Bio for Coffee at the CMO Summit

Join us from 7-9 AM on April 7th at the Chief Medical Officer Summit 360°, the largest gathering of physicians in biotech.

We’ll be serving coffee and snacks for attendees at the event.

Learn more and sign up!



Webinar On-Demand

Biopharma BD meets AI: Accelerating due diligence to find the right assets

How AI analysis supports drug development


After watching this webinar, you’ll have a clear understanding of:

  • Why traditional drug development analysis is more difficult than ever
  • How an AI-powered pipeline analysis platform can improve decision-making speed and accuracy
  • The important role human expertise plays in an AI-powered platform in delivering optimal outcomes

Additional resources

I recently sat down with a Top 20 pharmaceutical company to discuss their goals and struggles for the year ahead and how pharma portfolio analytics fits in.
Recently, I had a conversation with Dr. Kanya Rajangam, to discuss current perceptions about Chinese biotech, opportunities, language challenges, and risks.
Chinese biopharma companies are at an inflection point, with rapidly advancing in science, know-how, + talent. Chinese assets are poised to reshape drug development.
Based on JPM 2025, it’s safe to say that the biotech industry is experiencing a broad resurgence, with subtle yet significant disruption beneath the surface.
By combining human expertise with AI-powered analysis, we're helping biopharma companies make faster, more informed business development decisions.
Artificial intelligence-powered pipeline analysis is emerging as a tool that can help teams make better, faster drug development decisions.

Uncover new possibilities with VibeOne

Learn how VibeOne can help you discover your next indication or identify high potential development opportunities in your portfolio.